SEC Form 4 · accession 0001645627-18-000058
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 10, 2018
Accepted (ET)
Sep 14, 2018 · 11:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 10, 2018 | P | 1,000 | $0.0365 | A | 25,910,798 | D | |
| Common Stock | Sep 10, 2018 | P | 1,000 | $0.0362 | A | 25,911,798 | D | |
| Common Stock | Sep 10, 2018 | P | 1,000 | $0.0358 | A | 25,912,798 | D | |
| Common Stock | Sep 10, 2018 | P | 1,000 | $0.0341 | A | 25,913,798 | D | |
| Common Stock | Sep 10, 2018 | P | 1,000 | $0.0341 | A | 25,914,798 | D | |
| Common Stock | Sep 13, 2018 | P | 2,000 | $0.0482 | A | 25,916,798 | D |
Table II — derivative securities
No Table II lines on this filing.